IntelliPharmaCeutics International (IPCI)
IntelliPharmaCeutics International Market Cap: 47.09M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
IPCI Market Cap Rankings
| Overall | 13th percentile | 4016 of 4663 |
| Sector | 18th percentile | 427 of 525 in Healthcare |
| Industry | 7th percentile | 12 of 13 in Drug Delivery & Accessories |
IPCI Market Cap Range, Past 5 Years
| Minimum | 17.89M | Feb 2010 |
| Maximum | 66.07M | Feb 2011 |
| Average | 41.07M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these IPCI related companies
IPCI News
$IPCI Husband-and-wife team's winning formula @ CNN (Video) http://stks.co/410Y
about a day ago by IPCI
about a day ago by IPCI
$IPCI Intellipharmaceutics Meets a 2012 Goal for Abuse-Deterrent Oxycodone http://stks.co/3bVF
about 29 days ago by IPCI
about 29 days ago by IPCI
Intellipharmaceutics Announces First Quarter 2012 Results ($IPCI) http://stks.co/3MZm
about 44 days ago by IPCI
about 44 days ago by IPCI
$IPCI FDA Releases Draft Guidance on dexmethylphenidate hydrochloride http://stks.co/38Wi
about 62 days ago by IPCI
about 62 days ago by IPCI
Intellipharmaceutics Announces Webcast of Presentation at the 11th Annual Needham Healthcare Conference - $IPCI http://stks.co/36Cb
about 64 days ago by IPCI
about 64 days ago by IPCI
Intellipharmaceutics Announces Webcast of Presentation at the 11th Annual Needham Healthcare Conference
Mar 27, 8:00AM GlobeNewswire
Mar 27, 8:00AM GlobeNewswire
$IPCI Intellipharmaceutics Appoints VP of Business Development @ HealthCare Distributor http://stks.co/34xP
about 65 days ago by IPCI
about 65 days ago by IPCI
Intellipharmaceutics $IPCI Closes US$5,000,000 Registered Direct Offering of Common Shares http://stks.co/30C1
about 70 days ago by IPCI
about 70 days ago by IPCI
Intellipharmaceutics Closes US$5,000,000 Registered Direct Offering of Common Shares
Mar 15, 5:00PM GlobeNewswire
Mar 15, 5:00PM GlobeNewswire
Intellipharmaceutics (IPCI) Enters $5M Registered Direct Offering at $2.75/Share
Mar 09, 9:15AM Street Insider
Mar 09, 9:15AM Street Insider
Intellipharmaceutics to Present at Upcoming Cowen Healthcare and Roth Conferences
Feb 17, 8:00AM GlobeNewswire
Feb 17, 8:00AM GlobeNewswire
$BPAX uggh. If $IPCI takes out $3.80 get in. It clears that range its free run to $4.90. Lower trading vol than $BPAX.
about 113 days ago by mentholatum
about 113 days ago by mentholatum
$TVIX down, $BPAX up more, $IPCI is L-vol BO, should roll up to $4.90ish from $3.60. Watching Cramer dissing of $MX for tinyshort.
about 113 days ago by mentholatum
about 113 days ago by mentholatum
Let 3K more go AH. Incredibly strong stock here. 2K left are free..$BPAX ... also watch. $IPCI L-Vol B-O will be heading up Tues.
about 114 days ago by mentholatum
about 114 days ago by mentholatum
Took half off $BPAX at close... up .22 so I'll hold 5k till tomorrow.. Put $IPCI on watchlist. Get it above $3.80 on a break to $4.90
about 114 days ago by mentholatum
about 114 days ago by mentholatum
Intellipharmaceutics Announces Webcast of Presentation at the Biotech Showcase 2012
Jan 05, 4:30PM GlobeNewswire
Jan 05, 4:30PM GlobeNewswire
Intellipharmaceutics files shelf prospectus, shelf registration statement
Nov 26, 12:35PM FlyOnTheWall
Nov 26, 12:35PM FlyOnTheWall
Intellipharmaceutics Files Preliminary Base Shelf Prospectus and Shelf Registration Statement
Nov 25, 5:14PM GlobeNewswire
Nov 25, 5:14PM GlobeNewswire
$IPCI Intellipharmaceutics' Manufacturing Facility Passes FDA cGMP and Pre-Approval Inspection http://stks.co/1FqW
about 189 days ago by IPCI
about 189 days ago by IPCI
$IPCI Intellipharmaceutics Announces Webcast of Presentation at the 23rd Annual Piper Jaffray Healthcare Conference http://stks.co/1FqO
about 189 days ago by IPCI
about 189 days ago by IPCI
Intellipharmaceutics Announces Webcast of Presentation at the 23rd Annual Piper Jaffray Healthcare Conference
Nov 23, 12:30PM GlobeNewswire
Nov 23, 12:30PM GlobeNewswire
Intellipharmaceutics' Manufacturing Facility Passes FDA cGMP and Pre-Approval Inspection
Nov 15, 8:29AM Benzinga
Nov 15, 8:29AM Benzinga
Intellipharmaceutics (IPCI) Toronto Facility Completes cGMP, Pre-Approval Inspection Process
Nov 15, 7:09AM Street Insider
Nov 15, 7:09AM Street Insider
Intellipharmaceutics facility passes FDA cGMP and pre-approval inspection
Nov 15, 6:10AM FlyOnTheWall
Nov 15, 6:10AM FlyOnTheWall
FDA Accepts for Filing Intellipharmaceutics' ANDA for Generic Lamictal(R) XR(TM)
Oct 31, 8:30AM GlobeNewswire
Oct 31, 8:30AM GlobeNewswire
Ladenburg Thalmann Maintains Buy Rating and $7 PT on IntelliPharmaCeutics International
Oct 10, 9:12AM Benzinga
Oct 10, 9:12AM Benzinga
Intellipharmaceutics Announces Webcast of Presentation at the JMP Securities Healthcare Conference
Sep 26, 11:30AM GlobeNewswire
Sep 26, 11:30AM GlobeNewswire
Intellipharmaceutics and Par Expand Development and Commercialization Agreement $IPCI $PRX http://stks.co/PK
about 286 days ago by IPCI
about 286 days ago by IPCI
Intellipharmaceutics and Par Pharmaceutical Expand Development and Commercialization Agreement
Aug 18, 6:00AM GlobeNewswire
Aug 18, 6:00AM GlobeNewswire
$IPCI http://chart.ly/syqgs2k chart request for @zerobid hope it helps!
about 306 days ago by traderstewie
about 306 days ago by traderstewie
($IPCI) Intellipharmaceutics Announces First Quarter 2011 Results http://stk.ly/hg5zmI
about 411 days ago by IntelliPharma
about 411 days ago by IntelliPharma
($IPCI) Intellipharmaceutics Announces First Quarter 2011 Results
about 411 days ago by IntelliPharma
about 411 days ago by IntelliPharma
($IPCI) Intellipharmaceutics Files ANDA With FDA For Generic Seroquel XR http://stk.ly/ggWvHh
about 422 days ago by IntelliPharma
about 422 days ago by IntelliPharma
($IPCI) Intellipharmaceutics Files ANDA With FDA For Generic Seroquel XR
about 422 days ago by IntelliPharma
about 422 days ago by IntelliPharma
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| IPCI | 2.96 | +0.00 | +0.00% | 47.09M |
| IPCC | 54.03 | -0.58 | -1.06% | 644.40M |
| IPAS | 2.35 | -0.03 | -1.26% | 141.06M |
| IPAR | 15.45 | -0.29 | -1.84% | 481.01M |
| IP | 29.33 | -0.59 | -1.97% | 13.08B |
| IOT | 1.67 | -0.06 | -3.47% | 6.964M |
| IOSP | 26.48 | -0.83 | -3.04% | 630.04M |
| IHS | 100.17 | -1.53 | -1.50% | 6.629B |
| IHI | 63.13 | -1.02 | -1.59% | |
| IHG | 22.28 | -0.51 | -2.24% | 6.634B |